HILL STEPHEN J. (Chief Technical Ops. Officer) sold 6.0% of their position (1K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $10.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/22/2025ACC: 0001415889-25-022746
Officer· Chief Technical Ops. Officer
Since Jun 2021
+7K
Net shares
Net buyer
$10.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
8K acquired · 1K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8K
Price / share
—
Trade value
—
% of position
90.4%
8/20/2025
8.85K→16.85K
Common Stock
Direct
Shares
−1K
Price / share
$10.54
Trade value
$10.59K
% of position
6.0%
8/21/2025
16.85K→15.85K
Total
Net shares
+7K
Net value
-$10.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2025 | A · Award | +8K | — | — | 90.4% | 8.85K | 16.85K |
| Common Stock Direct | 8/21/2025 | S · Sale | −1K | $10.54 | $10.59K | 6.0% | 16.85K | 15.85K |
| Total | +7K | -$10.59K | ||||||
Derivative Transactions0
No derivative transactions reported